FDA
approval
· 2025-10-06
FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
Summary
FDA approved a supplemental application for buspirone hydrochloride from Rising Pharma Holdings, Inc., allowing a change to an existing generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)